Skip to main content

Table 2 Baseline / follow-up assessments (visits 1 and 2)

From: Evaluating noninvasive brain stimulation to treat overactive bladder in individuals with multiple sclerosis: a randomized controlled trial protocol

Assessment

Score/Measurement

• Expanded Disability Status Score (EDSS)

0—10 (Normal to Mortal)

• American Urological Assoc Symptom Score (AUASS)

0—35 (Mild to Severe)

• Neurogenic Bladder Symptom Score (NBSS)

0—74 (Normal to Max Symptoms)

• Urogenital Distress Inventory (UDI-6)

0—100 (Normal to Max Symptoms)

• Incontinence Impact Questionnaire (IIQ-7)

0—100 (Normal to Max Impact)

• Hospital Anxiety and Depression Scale (HADS)

0—42 (No Anxiety to Severe Anxiety)

• Hamilton Depression Rating Scale (HAM-D)

0—54 (No Depression to Severe Depression)

• Hamilton Anxiety Rating Scale (HAM-A)

0—56 (No Anxiety to Severe Anxiety)

• MRI Safety Questionnaire

Q&A

• 2-day Bladder Diary

Q&A

• Non-Instrumented Uroflow

mL/sec

• Post-Void Residual (PVR) Volume

cm3